You may also be interested in...
The draft updates include a new recommendation on PSA thresholds for the referral of suspected urological cancer. They also cover the staging of prostate cancer.
Company led medicines recall: Irinotecan 200mg/ 260mL in sodium chloride 0.9% w/v intravenous infusion and Infliximab intravenous infusion in sodium chloride 0.9%
Qualasept Ltd t/a Bath ASU is recalling specific batches of these products due to risks of reduced product quality.